Search Results - Kuo, Yutzu

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    54168 Maximum-Use Trials of Ruxolitinib Cream in Adults, Adolescents, and Children Aged 2 to <12 Years With Atopic Dermatitis: Consistency of Safety, Pharmacokinetics, and Efficacy

    54168 Maximum-Use Trials of Ruxolitinib Cream in Adults, Adolescents, and Children Aged 2 to <12 Years With Atopic Dermatitis: Consistency of Safety, Pharmacokinetics, and Efficacy by Bissonnette, Robert, Tom, Wynnis L., Sturm, Daniel, Angel, Brett, Chen, Xuejun, Kuo, Yutzu, Lee, Mark S.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    625 - Efficacy and safety of 1.5% ruxolitinib cream in patients with facial and/or neck atopic dermatitis: a randomized, double-blind, decentralized phase 2 study

    625 - Efficacy and safety of 1.5% ruxolitinib cream in patients with facial and/or neck atopic dermatitis: a randomized, double-blind, decentralized phase 2 study by Chiesa Fuxench, Zelma C, Lai, Zhihong, Kuo, YuTzu, Nawaz, Haq, Cotliar, Jonathan

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8

    54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8 by Forman, Seth B., Zaenglein, Andrea L., Shepard, Julie S., Kallender, Howard, Angel, Brett, Kuo, Yutzu, Bissonnette, Robert

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial

    603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial by Bissonnette, Robert, Lee, Mark S, Forman, Seth B, Gold, Linda Stein, Kallender, Howard, Angel, Brett, Kuo, Yutzu, Paller, Amy S

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8weeks of ruxolitinib cream monotherapy

    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8weeks of ruxolit... by Simpson, Eric L, Kircik, Leon, Blauvelt, Andrew, Kallender, Howard, Kuo, Yutzu, Ren, Haobo, Sturm, Daniel, Eichenfield, Lawrence F

    Published in Journal of dermatology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

    Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study by Zirwas, Matthew, Halden, Philippa, Lai, Zhihong, Kuo, YuTzu, Nawaz, Haq, Stein Gold, Linda

    Published in Skin (Milwood, N.Y.)
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy

    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxoli... by Simpson, Eric L., Kircik, Leon, Blauvelt, Andrew, Kallender, Howard, Kuo, Yutzu, Ren, Haobo, Sturm, Daniel, Eichenfield, Lawrence F.

    Published in Journal of dermatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Parallelized Random Walk algorithm for background substitution on a multi-core embedded platform

    Parallelized Random Walk algorithm for background substitution on a multi-core embedded platform by Yutzu Lee, Chen-Kuo Chiang, Yu-Wei Sun, Te-Feng Su, Shang-Hong Lai

    Request full text
    Conference Proceeding
    Save to List
    Saved in:
  9. 9
    Parallelized Background Substitution System on a Multi-core Embedded Platform

    Parallelized Background Substitution System on a Multi-core Embedded Platform by Yutzu Lee, Chen-Kuo Chiang, Te-Feng Su, Yu-Wei Sun, Chi-Bang Kuan, Shang-Hong Lai

    Request full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: